Delivery Order 36F79722D0090-36C26026F0037
Award Date 10/1/25
Potential Completion Date 9/30/26
Potential Value $364K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is to Grifols USA LLC, a global healthcare company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of PROLASTIN, a pharmaceutical product, with a potential value of $59,192.70. The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is priced on a firm fixed price basis. The contract does not have a set-aside designation. Grifols USA LLC is the prime contractor...
- This federal contract award is for the delivery of PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, to the Department of Veterans Affairs (VA). The $111,000.00 firm fixed-price delivery order was awarded to Grifols USA LLC, a global healthcare company specializing in the development, manufacturing, and distribution of plasma-derived medicines and pharmaceutical supplies. The contract is not designated as a set-aside and is issued under the...
- This federal contract award is for the delivery of PROLASTIN-C 1000MG VIALS to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The contract was awarded to Grifols USA LLC, a global healthcare company that specializes in the development, manufacturing, and distribution of plasma-derived medicines and pharmaceutical supplies. The contract is a Delivery Order under Grifols' General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and...
- This federal contract award is for the delivery of PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, to the Department of Veterans Affairs (VA). The contract was awarded to Grifols USA LLC, a global healthcare company specializing in the development, manufacturing, and distribution of plasma-derived medicines, transfusion medicine products, and pharmaceutical supplies. The contract is a Delivery Order with a Firm Fixed Price of $120,000.00 and an ultimate...
- This is a federal contract award to Grifols USA LLC, a global healthcare company, by the Veterans Integrated Service Network 23 (VISN 23), a division of the U.S. Department of Veterans Affairs (VA). The contract is for the delivery of PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, as well as other pharmaceutical supplies. The contract is a firm fixed-price delivery order with a ceiling value of $138,415.20 and an ultimate completion date of April 30,...
- This is a federal contract award for PROLASTIN to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $219,999.96, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20 and did not utilize any small business set-asides. The contract is a delivery order under the Pharmaceuticals and Drugs General Services Administration (GSA) Federal Supply...
- This federal contract award is for PROLASTIN-C, a pharmaceutical product, awarded by the Department of Veterans Affairs Veterans Health Administration to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $355,273.02 firm fixed price delivery order is under the Pharmaceuticals and Drugs GSA Schedule contract vehicle and does not utilize any small business set-asides. Grifols Therapeutics has previously been awarded other federal...
- The Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a delivery order valued at $157,097.69 to Grifols USA LLC for the supply of PROLASTIN LIQUID, a plasma-derived pharmaceutical product used to treat alpha1-antitrypsin deficiency. This firm fixed-price delivery order, issued on May 20, 2024, with a completion date of September 30, 2024, was executed without a set-aside designation, reflecting Grifols' status as a large business capable of meeting federal...
- This federal contract award is for a Blanket Purchase Agreement (BPA) call from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 7 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of Prolastin, a pharmaceutical product, with a potential value of $125,209.92. The contract does not utilize any small business set-asides and is a Firm Fixed...
- The Department of Veterans Affairs Veterans Health Administration awarded Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, a $130,406.43 delivery order contract for PROLASTIN 1000MG/VIAL. The contract is a firm fixed price agreement issued under the Pharmaceuticals and Drugs GSA Schedule. This award does not utilize a small business set-aside. Grifols has previously provided pharmaceutical products such as Prolastin, Prolastin-C, and...